SCHEMBL30438366

SCHEMBL30438366

CC(=O)NC1CN(C(=O)OC(C)(C)C)CCN1C(=O)OC(C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ EPHX1 P07099 1/20 0.46
▸ HPGD P15428 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ MAPT P10636 1/20 0.41
▸ EPHX2 P34913 1/20 0.41
▸ USP2 O75604 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.39
▸ NR1H2 P55055 1/20 0.39
▸ NAMPT P43490 1/20 0.39
▸ USP30 Q70CQ3 1/20 0.38
▸ SETD7 Q8WTS6 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ STS P08842 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3940084 0.80 NPC1 (0.48) EPHX1HPGDALDH1A1MEN1KMT2A
SCHEMBL20583847 0.77 HSD17B10 (0.45) HPGDALDH1A1MEN1KMT2AMAPT
SCHEMBL27044057 0.77 HSD17B10 (0.45) HPGDALDH1A1MEN1KMT2AMAPT
SCHEMBL23779175 0.77 CA1 (0.57) EPHX1HPGDALDH1A1MEN1KMT2A
SCHEMBL13295381 0.77 CA1 (0.57) EPHX1HPGDALDH1A1MEN1KMT2A
SCHEMBL14564148 0.77 CA1 (0.57) EPHX1HPGDALDH1A1MEN1KMT2A
SCHEMBL4336794 0.76 SETD7 (0.52) EPHX1HPGDALDH1A1MEN1KMT2A
SCHEMBL6874691 0.76 EPHX1 (0.58) EPHX1ALDH1A1MAPTUSP30NPC1
SCHEMBL13934773 0.76 EPHX1 (0.58) EPHX1ALDH1A1MAPTUSP30NPC1
SCHEMBL1896900 0.76 EPHX1 (0.58) EPHX1ALDH1A1MAPTUSP30NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116120243-A aPKC inhibitor compound intermediate fragment, preparation method and application thereof 都创(上海)医药科技股份有限公司 2023-05-16 — — CN disclosed
Send feedback